vs

Side-by-side financial comparison of Axogen, Inc. (AXGN) and NORTHPOINTE BANCSHARES INC (NPB). Click either name above to swap in a different company.

NORTHPOINTE BANCSHARES INC is the larger business by last-quarter revenue ($63.4M vs $61.5M, roughly 1.0× Axogen, Inc.). NORTHPOINTE BANCSHARES INC runs the higher net margin — 34.9% vs -31.9%, a 66.8% gap on every dollar of revenue.

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

Northpointe Bancshares Inc is a U.S.-based bank holding company operating through its wholly-owned banking subsidiary. It provides a full suite of retail and commercial banking solutions, including deposit accounts, mortgage loans, small business lending, and wealth management services, primarily serving local and regional community markets across the United States.

AXGN vs NPB — Head-to-Head

Bigger by revenue
NPB
NPB
1.0× larger
NPB
$63.4M
$61.5M
AXGN
Higher net margin
NPB
NPB
66.8% more per $
NPB
34.9%
-31.9%
AXGN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AXGN
AXGN
NPB
NPB
Revenue
$61.5M
$63.4M
Net Profit
$-19.6M
$22.2M
Gross Margin
75.2%
Operating Margin
20.2%
Net Margin
-31.9%
34.9%
Revenue YoY
26.6%
Net Profit YoY
-410.8%
EPS (diluted)
$-0.38
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXGN
AXGN
NPB
NPB
Q1 26
$61.5M
$63.4M
Q4 25
$59.9M
$43.5M
Q3 25
$60.1M
$40.3M
Q2 25
$56.7M
$36.5M
Q1 25
$48.6M
$30.4M
Q4 24
$49.4M
Q3 24
$48.6M
Q2 24
$47.9M
Net Profit
AXGN
AXGN
NPB
NPB
Q1 26
$-19.6M
$22.2M
Q4 25
$-13.2M
$23.6M
Q3 25
$708.0K
$22.2M
Q2 25
$579.0K
$20.3M
Q1 25
$-3.8M
$17.2M
Q4 24
$450.0K
Q3 24
$-1.9M
Q2 24
$-1.9M
Gross Margin
AXGN
AXGN
NPB
NPB
Q1 26
75.2%
Q4 25
74.1%
Q3 25
76.6%
Q2 25
74.2%
Q1 25
71.9%
Q4 24
76.1%
Q3 24
74.9%
Q2 24
73.8%
Operating Margin
AXGN
AXGN
NPB
NPB
Q1 26
20.2%
Q4 25
-16.3%
73.5%
Q3 25
3.2%
72.3%
Q2 25
3.0%
73.0%
Q1 25
-3.4%
74.4%
Q4 24
4.1%
Q3 24
-0.6%
Q2 24
-0.9%
Net Margin
AXGN
AXGN
NPB
NPB
Q1 26
-31.9%
34.9%
Q4 25
-22.0%
54.4%
Q3 25
1.2%
55.0%
Q2 25
1.0%
55.7%
Q1 25
-7.9%
56.8%
Q4 24
0.9%
Q3 24
-3.8%
Q2 24
-4.0%
EPS (diluted)
AXGN
AXGN
NPB
NPB
Q1 26
$-0.38
$0.62
Q4 25
$-0.28
$0.54
Q3 25
$0.01
$0.57
Q2 25
$0.01
$0.51
Q1 25
$-0.08
$0.49
Q4 24
$-0.00
Q3 24
$-0.04
Q2 24
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXGN
AXGN
NPB
NPB
Cash + ST InvestmentsLiquidity on hand
$82.7M
$487.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$244.8M
$590.0M
Total Assets
$289.5M
$7.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXGN
AXGN
NPB
NPB
Q1 26
$82.7M
$487.6M
Q4 25
$41.5M
$496.5M
Q3 25
$35.8M
$419.2M
Q2 25
$29.9M
$415.7M
Q1 25
$22.1M
$321.5M
Q4 24
$33.5M
Q3 24
$24.5M
Q2 24
$21.1M
Total Debt
AXGN
AXGN
NPB
NPB
Q1 26
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
AXGN
AXGN
NPB
NPB
Q1 26
$244.8M
$590.0M
Q4 25
$128.8M
$569.0M
Q3 25
$120.8M
$623.5M
Q2 25
$112.3M
$604.3M
Q1 25
$105.4M
$586.5M
Q4 24
$103.9M
Q3 24
$99.4M
Q2 24
$95.7M
Total Assets
AXGN
AXGN
NPB
NPB
Q1 26
$289.5M
$7.4B
Q4 25
$221.7M
$7.0B
Q3 25
$216.4M
$6.8B
Q2 25
$205.5M
$6.4B
Q1 25
$196.2M
$5.9B
Q4 24
$203.7M
Q3 24
$192.0M
Q2 24
$188.9M
Debt / Equity
AXGN
AXGN
NPB
NPB
Q1 26
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXGN
AXGN
NPB
NPB
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXGN
AXGN
NPB
NPB
Q1 26
Q4 25
$3.0M
$-28.3M
Q3 25
$3.2M
$90.4M
Q2 25
$7.7M
$-72.3M
Q1 25
$-13.2M
$54.4M
Q4 24
$8.7M
Q3 24
$3.9M
Q2 24
$4.2M
Free Cash Flow
AXGN
AXGN
NPB
NPB
Q1 26
$-1.4M
Q4 25
$1.8M
$-28.8M
Q3 25
$1.7M
$89.6M
Q2 25
$7.0M
$-73.4M
Q1 25
$-13.4M
$54.1M
Q4 24
$8.1M
Q3 24
$3.3M
Q2 24
$3.3M
FCF Margin
AXGN
AXGN
NPB
NPB
Q1 26
-2.3%
Q4 25
3.0%
-66.1%
Q3 25
2.8%
222.3%
Q2 25
12.4%
-201.1%
Q1 25
-27.7%
178.0%
Q4 24
16.3%
Q3 24
6.8%
Q2 24
6.8%
Capex Intensity
AXGN
AXGN
NPB
NPB
Q1 26
Q4 25
2.1%
1.2%
Q3 25
2.5%
2.0%
Q2 25
1.3%
3.1%
Q1 25
0.5%
1.1%
Q4 24
1.4%
Q3 24
1.2%
Q2 24
1.9%
Cash Conversion
AXGN
AXGN
NPB
NPB
Q1 26
Q4 25
-1.20×
Q3 25
4.55×
4.08×
Q2 25
13.35×
-3.55×
Q1 25
3.16×
Q4 24
19.41×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXGN
AXGN

Segment breakdown not available.

NPB
NPB

Net Interest Income$41.3M65%
Noninterest Income$22.1M35%

Related Comparisons